Ceric Sàrl clinical trials
The registry lists 17 studies whose lead sponsor is Ceric Sàrl. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 7, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 17studies on the registry
- 11open to participants now
- 2reach primary completion within a year
Get an email when these change. Save the Ceric Sàrl studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
2 of Ceric Sàrl’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- 1FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- 1AAug
- SSep
- OOct
- NNov
All 2
- Feb 2027TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.NCT06887413
- Aug 2027PASCAL Precision-GDMT RegistryNCT07578129
Add all 2 to your calendar (.ics) → With an account.
All 17 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 626
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ceric Sàrl.
- Ceric Sàrl17 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 17 of 17.
- Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe ARNot yet recruitingNCT07751965Not applicable
- Coronary Laser Atherectomy Registry From an International TaskforceRecruitingNCT07348341
- Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasENot yet recruitingNCT07602790Not applicable
- PASCAL Precision-GDMT RegistryNot yet recruitingNCT07578129
- Surgical vs Transcatheter Aortic Valve Replacement in YOUNG PatientsRecruitingNCT06861361Not applicable
- Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy AloneRecruitingNCT07038408Not applicable
- TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.RecruitingNCT06887413Not applicable
- The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary BifurcationsNot yet recruitingNCT06822322Not applicable
- Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta PathologiesRecruitingNCT05479305Not applicable
- Feasibility Study Evaluating the Safety and Efficacy of the Renal Stimulation by Direct Wire Pacing, During Renal Denervation ProcedureNot yet recruitingNCT06235554Not applicable
- All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable ValveNot yet recruitingNCT05989074Not applicable
- The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve StenosisActive, not recruitingNCT05847751
- Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.CompletedNCT02099617Not applicable
- Keep bIfurcation Single Stenting SimpleActive, not recruitingNCT04285372Not applicable
- Physio PCI: Impact of Coronary Angioplasty on Non-hyperaemic Pressure Ratio in Patients With Coronary Artery DiseaseTerminatedNCT04679805
- CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardiac Arrest PatientsTerminatedNCT04431661
- Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation IICompletedNCT03192813